Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts

Virology
Patrizia CaposioGiorgio Gribaudo

Abstract

The Human Cytomegalovirus (HCMV) UL72 gene is considered to be the equivalent of the dUTPase gene of the Alpha- and Gamma-herpesviruses. To characterize its function, the expression profiles of UL72 at both the RNA and the protein level were determined. The gene is expressed with a late kinetics and the corresponding UL72 46-kDa protein accumulates late during infection in the cytoplasm of infected cells. The pUL72 was expressed in E. coli and the purified recombinant protein did not display a detectable dUTPase activity. The viral yields of reconstituted HCMV RVDeltaUL72 viruses carrying a deletion within the UL72 ORF demonstrated a moderate growth defect following low MOI infections, whereas their DNA synthesis profiles were not significantly different from those of the parental HCMV RVAD169. These results demonstrate that the UL72 gene product is not a dUTPase and is not essential for replication in human fibroblasts.

References

Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E M McIntoshR H Haynes
Jan 1, 1991·DNA Sequence : the Journal of DNA Sequencing and Mapping·A T BankierE Preddie
Jul 1, 1988·The Journal of General Virology·D J McGeochP Taylor
Jan 1, 1984·Advances in Enzyme Regulation·F MaleyG Maley
Jan 1, 1997·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·J M HarrisE M McIntosh
Jun 6, 1998·Trends in Microbiology·H HengelU H Koszinowski
Feb 1, 2000·Immunology Today·A S LalaniG McFadden
Mar 9, 2000·Trends in Microbiology·E A FortunatoD H Spector
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Dec 2, 2000·Nature Biotechnology·Y ZhangA F Stewart
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·K A SimmenK Früh
Jun 5, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Michael A Jarvis, Jay A Nelson
Sep 19, 2002·The Journal of General Virology·Renxiang ChenLouis M Mansky
Oct 9, 2002·Current Protein & Peptide Science·J E McGeehanD J McGeoch
Oct 11, 2002·Current Protein & Peptide Science·A W StudebakerM V Williams
Dec 6, 2002·The Journal of General Virology·Giorgio GribaudoSanto Landolfo
Mar 14, 2003·Journal of Virology·Isidore RigoutsosThomas Shenk
May 29, 2003·The Journal of General Virology·Giorgio GribaudoSanto Landolfo
Jun 5, 2003·Pharmacology & Therapeutics·Santo LandolfoDavid Lembo
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Dong YuThomas Shenk
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Walter DunnFenyong Liu
Oct 2, 2008·Evolution; International Journal of Organic Evolution·Rhitoban RaychoudhuryJohn H Werren

❮ Previous
Next ❯

Citations

Sep 29, 2005·Journal of Virology·Andrew J Davison, Nigel D Stow
Jun 7, 2008·Retrovirology·Joséphine SireStéphane Priet
Jun 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Robert F Kalejta
Nov 8, 2008·Trends in Biochemical Sciences·David Lembo, Wolfram Brune
Oct 14, 2014·Frontiers in Microbiology·Maria Eugenia ArizaMarshall V Williams
Apr 28, 2005·Brain, Behavior and Evolution·Lainy B DayDeborah H Olster
Aug 9, 2020·Frontiers in Microbiology·Yu-Qing Wang, Xiang-Yu Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.